Investigation Report on Chinese Adalimumab Market, 2021-2025

SKU ID :CRI-17947253 | Published Date: 09-Apr-2021 | No. of pages: 40
Table of Contents 1 Relevant Concepts of Adalimumab 1.1 Indications for Adalimumab 1.2 Development of Adalimumab in China 1.3 Governmental Approval of Adalimumab in China 1.4 The Impact of COVID-19 on Adalimumab sales in China 2 Sales of Adalimumab in China, 2016-2020 2.1 Sales Value of Adalimumab 2.1.1 Overall Sales Value 2.1.2 Sales Value by Region 2.2 Sales Volume of Adalimumab 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Region 2.3 Sales of Adalimumab by Dosage Form in China, 2016-2020 2.3.1 Injection 2.3.2 Analysis of Other Dosage Forms 3 Analysis of Major Adalimumab Manufacturers in China, 2016-2020 3.1 Analysis of Market Share of Major Adalimumab Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 AbbVie Ltd. 3.2.1 Enterprise Profile 3.2.2 Sales of HUMIRA (AbbVie's Adalimumab) in China 3.3 Zhejiang Hisun Pharmaceutical Co., Ltd. 3.3.1 Enterprise Profile 3.3.2 Sales of Anjianning (Hisun's Adalimumab) in China 3.4 Bio-Thera Solutions, Ltd. 3.4.1 Enterprise Profile 3.4.2 Sales of OLETLI (Bio-Thera's Adalimumab) in China 3.5 Innovent Biologics (Suzhou) Co., Ltd. 3.5.1 Enterprise Profile 3.5.2 Sales of SULINNO(Innovent's Adalimumab) in China 4 Prices of Adalimumab for Different Manufacturers in China, 2020-2021 4.1 AbbVie Ltd. (HUMIRA) 4.2 Zhejiang Hisun Pharmaceutical Co., Ltd. (Anjianning) 4.3 Bio-Thera Solutions, Ltd. (OLETLI) 4.4 Innovent Biologics (Suzhou) Co., Ltd. (SULINNO) 5 Prospect of Chinese Adalimumab drug Market, 2021-2025 5.1 Influential Factors of Chinese Adalimumab Market Development 5.1.1 The Impact of COVID-19 on Chinese Adalimumab Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Adalimumab Injection Registration in China Chart Sales Value of Adalimumab Injection over the World Chart Sales Value of Adalimumab Injection in China, 2016-2020 Chart Sales Value of Adalimumab Injection in China by Regions, 2016-2020 Chart Sales Volume of Adalimumab Injection in China, 2016-2020 Chart Sales Volume of Adalimumab Injection in China by Regions, 2016-2020 Chart Market Share by Sales Value of Top Adalimumab Manufacturers in China, 2016-2020 Chart Market Share by Sales Volume of Top Adalimumab Manufacturers in China, 2016-2020 Chart Sales Value and Volume of HUMIRA in China, 2016-2020 Chart Sales Value and Volume of Anjianning in China, 2016-2020 Chart Sales Value and Volume of OLETLI in China, 2016-2020 Chart Sales Value and Volume of SULINNO, 2016-2020 Chart Referential Prices of HUMIRA in China, 2020-2021 Chart Referential Prices of Anjianning in China, 2020-2021 Chart Referential Prices of OLETLI in China, 2020-2021 Chart Referential Prices SULINNO in China, 2020-2021 Chart Forecast on Sales Value of Adalimumab in China, 2021-2025 Chart Forecast on Sales Volume of Adalimumab in China, 2021-2025
  • PRICE
  • $2600
    $3900
    Buy Now

Our Clients